Search

everythinglearnresearchcommunity

for

Search:↓

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.

Certain alkaloids could help create new coronavirus drugs.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

COVID-19 may cause hair loss by affecting hair follicles.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

Stress and COVID-19 can worsen hair loss conditions like alopecia areata.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss has many causes and treatments, but future research aims for better solutions.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

An 11-year-old girl's hair loss was caused by a Cladosporium fungal infection, which was cured with itraconazole treatment.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Sex hormone supplements help improve breathing and nerve recovery after spinal injury in rats.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.